With the increasing introduction of new innovative medical products including digital therapeutics amid intensifying competition among countries to rapidly secure new technologies, South Korea is feeling the urgent need to shift its focus more to a regulatory science-based approach.
MFDS Forum Highlights Korea’s Shift To Regulatory Science Approach
Regulation Lag, Expertise Among Issues
At a recent forum organized by South Korea’s drug ministry, participants discussed why a regulatory science-based approach is needed, what issues in this area are being faced by the country and which directions it should be headed.
